CD56+ NK cells and immature DCs showed much stronger signals in the hypermetabolic tumor areas than in the hypometabolic ones, indicating that hypermetabolic tumors might be more prone to be associated with innate immune responses. This evidence concerns the gene NCAM1 and neoplasm.